Finance

Lists
ETON:NASDAQ
Eton Pharmaceuticals Inc
USD 63,88
-0,08%
(-0,050) 1D
USD 63,88
0,00% (0,00)
After hours
Closed: 16 Nov., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ETON...
Open
USD 64,29
High
USD 66,73
Low
USD 63,50
Mkt. cap
1,84 mjd
Avg. vol.
562,37 k
Volume
613,62 k
P/E ratio
42,11
52-wk high
USD 70,64
52-wk low
USD 14,27
EPS
USD 1,52
Beta
0,89
Shares outstanding
28,84 m
No. of employees
44
Open
USD 64,29
High
USD 66,73
Low
USD 63,50
Mkt. cap
1,84 mjd
Avg. vol.
562,37 k
Volume
613,62 k
P/E ratio
42,11
52-wk high
USD 70,64
52-wk low
USD 14,27
EPS
USD 1,52
Beta
0,89
Shares outstanding
28,84 m
No. of employees
44
News stories
From web sources and news partners
About Eton Pharmaceuticals Inc
CEO-
Employees44
Founded2017
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Analyst ratings
Based on 4 analysts giving stock ratings to ETON in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ETON in the last 3 months.
Highest
Current USD 63,88
USD 82,00 (+28,37%)
Average
USD 80,75 (+26,41%)
Lowest
USD 80,00 (+25,23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Madison Elsaadi
B. Riley Securities
Buy
Maintained
USD 81,00
+26,8%
11/10/2026
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
USD 82,00
+28,4%
11/06/2026
Gary Nachman
Canaccord Genuity
Buy
Reiterated
USD 80,00
+25,2%
11/06/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
USD 80,00
+25,2%
11/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
21,28 m
24,27 m
37,59 m
57,92 m
Cost of goods sold
6,76 m
9,18 m
11,53 m
13,15 m
Cost of revenue
6,76 m
9,18 m
11,53 m
13,15 m
Research and development expenses
1,78 m
1,88 m
993,00 k
5,27 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,28 m
10,45 m
11,63 m
16,02 m
Operating expense
10,06 m
12,32 m
12,62 m
21,29 m
Total operating expenses
16,82 m
21,50 m
24,14 m
34,44 m
Operating income
4,47 m
2,76 m
13,44 m
23,48 m
Other non operating income
-909,00 k
-
-
303,00 k
EBT including unusual items
1,41 m
1,57 m
11,72 m
22,36 m
EBT excluding unusual items
3,42 m
1,92 m
12,37 m
22,83 m
Income tax expense
-69,00 k
20,00 k
140,00 k
-12,89 m
Effective tax rate
-4,88%
1,27%
1,19%
-57,66%
Other operating expenses
-
-
-
-
Net income
1,48 m
1,55 m
11,58 m
35,25 m
Net profit margin
6,97%
6,40%
30,80%
60,85%
Earnings per share
0,19
0,14
0,43
0,50
Interest and investment income
1,07 m
296,00 k
-
-
Interest expense
-1,21 m
-1,14 m
-1,08 m
-959,00 k
Net interest expenses
-141,00 k
-840,00 k
-1,08 m
-959,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
5,48 m
3,90 m
14,83 m
24,93 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google-programme